Strategic Research and Innovation Agenda on Antimicrobial Resistance

  10 May 2019

The Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) 1 is an international collaborative platform coordinating and funding research on antimicrobial resistance (AMR). JPIAMR facilitates alignment of research programmes between member countries, as well as initiating and coordinating international funding initiatives on AMR through its Strategic Research and Innovation Agenda (SRIA). Through implementation of the SRIA, the JPIAMR supports research on the development of new therapies, stewardship of new and existing antibiotics, and strategies to monitor and prevent the spread of AMR between humans, animals, and the environment in a One Health2 perspective, with the overall goal to decrease the burden of AMR. The SRIA defines six priority topics through which coordinated research activities are translated into new and/or improved strategies to address AMR.

The JPIAMR goals are:
• To align national and international research programmes.
• To support and coordinate transformative research.
• To develop the JPIAMR-Virtual Research Institute.
• To promote innovation and translation of research results.
• To bridge the gap between research and policy.

Further reading: JPIAMR
Smart Innovations  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition


JSS University


Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!